Sign up for FlowVella
Sign up with FacebookAlready have an account? Sign in now
By registering you are agreeing to our
Terms of Service
Loading Flow
DISCUSSION

虽然在STEMI治疗方面,已经取得了很大进展,仍有高死亡率。作为三期临床试验,PLATO试验比较替格瑞洛与氯吡格雷除了阿司匹林在超过18000的ACS患者。结果显示在12个月显著降低主要功效结果(血管导致的死亡的复合端点,心肌梗死或中风) (9.8%替格瑞洛与氯吡格雷11.7%;p < 0.001)。